ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value ($000): $166,871 (100.0% shares, 0.0% debt)

Holdings (22)

WGS GENEDX HOLDINGS CORP 26.6%

Value ($000) $44,382 Shares 1,045,768 Est. Cost $6.26 Unrealized +439.9%

BHVN BIOHAVEN LTD 21.1%

Value ($000) $35,241 Shares 705,250 Est. Cost $17.30 Unrealized +124.9%

— BIOHAVEN LTD 9.1%

Value ($000) $15,126 Shares 302,700 Est. Cost — Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 8.1%

Value ($000) $13,551 Shares 749,487 Est. Cost $12.87 Unrealized +8.6%

— SPDR SER TR 5.9%

Value ($000) $9,880 Shares 100,000 Est. Cost — Unrealized —

ARDX ARDELYX INC 5.7%

Value ($000) $9,434 Shares 1,369,200 Est. Cost $5.85 Unrealized +0.8%

— NOVAVAX INC 4.0%

Value ($000) $6,752 Shares 534,600 Est. Cost — Unrealized —

QDEL QUIDELORTHO CORP 3.2%

Value ($000) $5,394 Shares 118,291 Est. Cost $99.04 Unrealized -59.2%

BCRX BIOCRYST PHARMACEUTICALS INC 2.4%

Value ($000) $4,070 Shares 535,558 Est. Cost $4.97 Unrealized +52.8%

MYGN MYRIAD GENETICS INC 2.2%

Value ($000) $3,684 Shares 134,500 Est. Cost $24.78 Unrealized +9.2%

— PHATHOM PHARMACEUTICALS INC 2.1%

Value ($000) $3,484 Shares 192,700 Est. Cost — Unrealized —

— ARDELYX INC 1.8%

Value ($000) $2,964 Shares 430,200 Est. Cost — Unrealized —

FORA FORIAN INC 1.8%

Value ($000) $2,929 Shares 1,356,107 Est. Cost $10.60 Unrealized -77.0%

— EYEPOINT PHARMACEUTICALS INC 1.7%

Value ($000) $2,797 Shares 350,000 Est. Cost — Unrealized —

CAVA CAVA GROUP INC 1.4%

Value ($000) $2,304 Shares 18,600 Est. Cost $54.87 Unrealized +85.2%

PACB PACIFIC BIOSCIENCES CALIF IN 0.7%

Value ($000) $1,237 Shares 727,877 Est. Cost $4.70 Unrealized -65.1%

— SPRINGWORKS THERAPEUTICS INC 0.7%

Value ($000) $1,096 Shares 34,200 Est. Cost $44.48 Unrealized —

PLTR PALANTIR TECHNOLOGIES INC 0.6%

Value ($000) $1,023 Shares 27,500 Est. Cost $30.69 Unrealized 0.0%

— PALANTIR TECHNOLOGIES INC 0.4%

Value ($000) $744 Shares 20,000 Est. Cost — Unrealized —

BIIB BIOGEN INC 0.3%

Value ($000) $468 Shares 2,412 Est. Cost $213.68 Unrealized -2.1%

EYPT EYEPOINT PHARMACEUTICALS INC 0.2%

Value ($000) $260 Shares 32,500 Est. Cost $12.95 Unrealized -32.2%

— BIODESIX INC 0.0%

Value ($000) $51 Shares 28,916 Est. Cost $1.71 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
WGS	GENEDX HOLDINGS CORP	1,045,768	$44,382	26.6%	$6.26	+439.9%	COM CL A	81663L200
BHVN	BIOHAVEN LTD	705,250	$35,241	21.1%	$17.30	+124.9%	COM	G1110E107
—	BIOHAVEN LTD	302,700	$15,126	9.1%	—	—	Call	G1110E907
PHAT	PHATHOM PHARMACEUTICALS INC	749,487	$13,551	8.1%	$12.87	+8.6%	COM	71722W107
—	SPDR SER TR	100,000	$9,880	5.9%	—	—	Call	78464A900
ARDX	ARDELYX INC	1,369,200	$9,434	5.7%	$5.85	+0.8%	COM	039697107
—	NOVAVAX INC	534,600	$6,752	4.0%	—	—	Call	670002901
QDEL	QUIDELORTHO CORP	118,291	$5,394	3.2%	$99.04	-59.2%	COM	219798105
BCRX	BIOCRYST PHARMACEUTICALS INC	535,558	$4,070	2.4%	$4.97	+52.8%	COM	09058V103
MYGN	MYRIAD GENETICS INC	134,500	$3,684	2.2%	$24.78	+9.2%	COM	62855J104
—	PHATHOM PHARMACEUTICALS INC	192,700	$3,484	2.1%	—	—	Call	71722W907
—	ARDELYX INC	430,200	$2,964	1.8%	—	—	Call	039697907
FORA	FORIAN INC	1,356,107	$2,929	1.8%	$10.60	-77.0%	COM	34630N106
—	EYEPOINT PHARMACEUTICALS INC	350,000	$2,797	1.7%	—	—	Call	30233G909
CAVA	CAVA GROUP INC	18,600	$2,304	1.4%	$54.87	+85.2%	COM	148929102
PACB	PACIFIC BIOSCIENCES CALIF IN	727,877	$1,237	0.7%	$4.70	-65.1%	COM	69404D108
—	SPRINGWORKS THERAPEUTICS INC	34,200	$1,096	0.7%	$44.48	—	COM	85205L107
PLTR	PALANTIR TECHNOLOGIES INC	27,500	$1,023	0.6%	$30.69	0.0%	CL A	69608A108
—	PALANTIR TECHNOLOGIES INC	20,000	$744	0.4%	—	—	Call	69608A908
BIIB	BIOGEN INC	2,412	$468	0.3%	$213.68	-2.1%	COM	09062X103
EYPT	EYEPOINT PHARMACEUTICALS INC	32,500	$260	0.2%	$12.95	-32.2%	COM NEW	30233G209
—	BIODESIX INC	28,916	$51	0.0%	$1.71	—	COM	09075X108